Aptamer Group Past Earnings Performance
Past criteria checks 0/6
Aptamer Group's earnings have been declining at an average annual rate of -36.4%, while the Biotechs industry saw earnings growing at 7.7% annually. Revenues have been declining at an average rate of 20.6% per year.
Key information
-36.4%
Earnings growth rate
-11.1%
EPS growth rate
| Biotechs Industry Growth | 11.5% |
| Revenue growth rate | -20.6% |
| Return on equity | -333.5% |
| Net Margin | -344.0% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How Aptamer Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 1 | -3 | 3 | 0 |
| 31 Mar 24 | 1 | -5 | 4 | 0 |
| 31 Dec 23 | 1 | -7 | 4 | 0 |
| 30 Sep 23 | 1 | -7 | 4 | 0 |
| 30 Jun 23 | 2 | -8 | 5 | 0 |
| 31 Mar 23 | 3 | -6 | 6 | 0 |
| 31 Dec 22 | 4 | -4 | 6 | 0 |
| 30 Sep 22 | 4 | -3 | 6 | 0 |
| 30 Jun 22 | 4 | -2 | 5 | 0 |
| 31 Dec 21 | 2 | -2 | 3 | 0 |
| 30 Sep 21 | 2 | -2 | 3 | 0 |
| 30 Jun 21 | 1 | -2 | 3 | 0 |
| 31 Mar 20 | 1 | -1 | 1 | 0 |
| 31 Mar 19 | 1 | 0 | 1 | 0 |
Quality Earnings: APTA is currently unprofitable.
Growing Profit Margin: APTA is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: APTA is unprofitable, and losses have increased over the past 5 years at a rate of 36.4% per year.
Accelerating Growth: Unable to compare APTA's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: APTA is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-18.2%).
Return on Equity
High ROE: APTA has a negative Return on Equity (-333.48%), as it is currently unprofitable.